Explore / Clinical trial
Clinical trial

Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients

The University of Texas Health Science Center, HoustonCompletedPhase 2Started Oct 14, 20169 enrolledUnited StatesNCT02935595

Abstract

The primary goal of the project is to study the effect of Ketamine on cortical neurophysiological function in TRD patients. The proposal employs robust and non-invasive neurophysiological techniques TMS and EEG to investigate the cortical excitability and oscillatory activity in patients with treatment resistant depression.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Treatment Resistant Depression

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.